- Home
- HBIO vs RVP Comparison
HBIO vs RVP Comparison
Compare HBIO & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- RVP
- Stock Information
- Founded
- HBIO 1901
- RVP 1994
- Country
- HBIO United States
- RVP United States
- Employees
- HBIO N/A
- RVP N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- RVP Medical/Dental Instruments
- Sector
- HBIO Industrials
- RVP Health Care
- Exchange
- HBIO Nasdaq
- RVP Nasdaq
- Market Cap
- HBIO 24.6M
- RVP 29.2M
- IPO Year
- HBIO 2000
- RVP 2001
- Fundamental
- Price
- HBIO $0.52
- RVP $0.83
- Analyst Decision
- HBIO Buy
- RVP
- Analyst Count
- HBIO 3
- RVP 0
- Target Price
- HBIO $2.50
- RVP N/A
- AVG Volume (30 Days)
- HBIO 18.1M
- RVP 252.1K
- Earning Date
- HBIO 11-06-2025
- RVP 11-14-2025
- Dividend Yield
- HBIO N/A
- RVP N/A
- EPS Growth
- HBIO N/A
- RVP N/A
- EPS
- HBIO N/A
- RVP N/A
- Revenue
- HBIO $88,750,000.00
- RVP $38,161,712.00
- Revenue This Year
- HBIO N/A
- RVP N/A
- Revenue Next Year
- HBIO $7.02
- RVP N/A
- P/E Ratio
- HBIO N/A
- RVP N/A
- Revenue Growth
- HBIO N/A
- RVP N/A
- 52 Week Low
- HBIO $0.28
- RVP $0.56
- 52 Week High
- HBIO $2.82
- RVP $1.14
- Technical
- Relative Strength Index (RSI)
- HBIO 54.48
- RVP 41.43
- Support Level
- HBIO $0.48
- RVP $0.83
- Resistance Level
- HBIO $0.65
- RVP $0.89
- Average True Range (ATR)
- HBIO 0.08
- RVP 0.07
- MACD
- HBIO 0.02
- RVP -0.02
- Stochastic Oscillator
- HBIO 24.98
- RVP 2.23
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.